Jyong Biotech Ltd.

Biotechnology • Healthcare • New Taipei City, Taiwan • MENS (NGM)

Jyong Biotech Ltd., a science-driven biotechnology company, develops and commercializes plant-derived drugs for the treatment of urinary system diseases in the United States, the European Union, and Asia. It develops MCS-2 for the treatment of benign prostate hyperplasia/lower urinary tract symptoms; PCP for treating prostate cancer; and interstitial cystitis (IC) for the treatment of IC/bladder pain syndrome. The company was founded in 2002 and is headquartered in New Taipei City, Taiwan.

886 2 2732 5205 No. 95, Xintai 5th Road, Taiwan

Stock Performance (90 Days)

Data through Dec 26, 2025

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Jyong Biotech (NASDAQ:MENS) Stock Price Down 19.3% - Here's What Happened - MarketBeat

MarketBeat • Dec 16

Evaluating Jyong Biotech (NasdaqGM:MENS): What Recent Price Moves Reveal About Its Current Valuation - Yahoo Finance

Yahoo Finance • Sep 14

Jyong Biotech Responds to Share Price and Volume Movement - GlobeNewswire

GlobeNewswire • Dec 19

Jyong Biotech stock soars after positive Phase II prostate cancer drug results - Investing.com

Investing.com • Nov 20

Jyong Biotech Stock (MENS) Opinions on Phase II Trial Results - Quiver Quantitative

Quiver Quantitative • Dec 2

Other Biotechnology Companies

Vertex Pharmaceuticals Inc. / MA

$118.68B market cap

Regeneron Pharmaceuticals, Inc.

$82.72B market cap

Alnylam Pharmaceuticals, Inc.

Frequently Asked Questions

Has Jyong Biotech Ltd. had layoffs?

No layoff events have been recorded for Jyong Biotech Ltd. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

What industry is Jyong Biotech Ltd. in?

Jyong Biotech Ltd. operates in the Biotechnology industry, within the Healthcare sector.

Is Jyong Biotech Ltd. a publicly traded company?

Yes, Jyong Biotech Ltd. is publicly traded under the ticker symbol MENS on the NGM. The company has a market capitalization of approximately $0.24 billion.

Where is Jyong Biotech Ltd. headquartered?

Jyong Biotech Ltd. is headquartered in New Taipei City, Taiwan at No. 95, Xintai 5th Road, Taiwan.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.